Truist Financial Corp Grows Position in Synopsys, Inc. $SNPS

Truist Financial Corp grew its stake in Synopsys, Inc. (NASDAQ:SNPS) by 80.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,044 shares of the semiconductor company’s stock after buying an additional 20,072 shares during the quarter. Truist Financial Corp’s holdings in Synopsys were worth $21,158,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in SNPS. Bellecapital International Ltd. boosted its position in shares of Synopsys by 1,477.8% in the fourth quarter. Bellecapital International Ltd. now owns 35,563 shares of the semiconductor company’s stock worth $16,705,000 after purchasing an additional 33,309 shares during the period. Montag A & Associates Inc. raised its position in shares of Synopsys by 3.8% during the 4th quarter. Montag A & Associates Inc. now owns 3,239 shares of the semiconductor company’s stock valued at $1,521,000 after purchasing an additional 118 shares during the period. PKO Investment Management Joint Stock Co lifted its stake in shares of Synopsys by 30.8% during the 4th quarter. PKO Investment Management Joint Stock Co now owns 8,500 shares of the semiconductor company’s stock valued at $3,993,000 after buying an additional 2,000 shares in the last quarter. Addison Capital Co bought a new position in Synopsys in the 4th quarter worth $670,000. Finally, PFA Pension Forsikringsaktieselskab bought a new position in Synopsys in the 4th quarter worth $52,124,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on SNPS. Piper Sandler decreased their price target on Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company dropped their price objective on Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys presently has an average rating of “Hold” and an average target price of $531.00.

Synopsys Stock Up 0.4%

SNPS opened at $504.42 on Thursday. The company has a market capitalization of $96.63 billion, a PE ratio of 78.33, a price-to-earnings-growth ratio of 4.11 and a beta of 1.25. The firm has a 50-day simple moving average of $433.00 and a two-hundred day simple moving average of $446.63. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. During the same period in the previous year, the firm posted $3.03 earnings per share. The business’s revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts forecast that Synopsys, Inc. will post 10.3 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.